Nielsaage Tøffner Clausen

Rituximab chimeric anti‐CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

Peter Brændstrup, Ole Weis Bjerrum, Ove Juul Nielsen et al. · American Journal of Hematology · 2005 · 135 citations

Life Sciences, Hematology, Immunology +17

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease.Relations to other prognostic factors and implications for choice of treatment

Lena Specht, A. M. Nordentoft, Nielsaage Tøffner Clausen et al. · Cancer · 1988 · 103 citations

Medicine, Oncology, Radiation Oncology +17

Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis

Hans Carl Hasselbalch, Ole Weiss Bjerrum, Bjarne Anker Jensen et al. · American Journal of Hematology · 2003 · 36 citations

Medicine, Hematology, Pharmacology +12

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases

Elisabeth I Penninga, B. A. Jensen, Per Brinch Hansen et al. · Clinical & Laboratory Haematology · 2004 · 34 citations · Full text

Medicine, Hematology, Pharmacology +7

Parvovirus B19 infection and Diamond‐Blackfan anaemia

ED Heegaard, Harry W. Hale, Nielsaage Tøffner Clausen et al. · Acta Paediatrica · 1996 · 30 citations

Medicine, Hematology, Infectious Diseases +17